p53 plays a critical role in regulating diverse biological processes: DNA repair, cell cycle arrest, apoptosis and senescence. The p53 pathway has therefore served as the focus of multiple drug-discovery efforts. p53 is negatively regulated by hDMX and hDM2; prior studies have identified 14-3-3 proteins as hDMX and hDM2 client proteins. 14-3-3 proteins are adaptor proteins that modulate localization, degradation and interactions of their targets in response to phosphorylation. Thus, 14-3-3 proteins may indirectly modulate the interaction between hDMX or hDM2 and p53 and represent potential targets for modulation of the p53 pathway. In this manuscript, we report on the biophysical and structural characterization of peptide/protein interactio...
SummaryCancer cells neutralize p53 by deletion, mutation, proteasomal degradation, or sequestration ...
The development of protein–protein interaction (PPI) inhibitors with therapeutic value is of increas...
Proteins that limit the activity of the tumour suppressor protein p53 are increasingly being targete...
p53 plays a critical role in regulating diverse biological processes: DNA repair, cell cycle arrest,...
p53 plays a critical role in regulating diverse biological processes: DNA repair, cell cycle arrest,...
p53 tumor suppressor activity is negatively regulated through binding to the oncogenic proteins Hdm2...
Upregulation of structurally homologous oncoproteins, Hdm2 and Hdmx, has been linked to the onset of...
The RING finger proteins HdmX and Hdm2 share significant structural and functional similarity. Hdm2 ...
The p53 tumor suppressor protein has a critical role in the cellular response to stress, and when ac...
Hdm2 (human MDM2) counteracts p53 function by direct binding to p53 and by ubiquitin-dependent p53 p...
We previously described a series of 314-helical β-peptides that bind the hDM2 protein and inhibit it...
Recently, we described a â-peptide foldamer, â53-1 (Figure 1A), that assembles into a 14-helix in aq...
Understanding how p53 activity is regulated is crucial in elucidating mechanisms of cellular defense...
The HDMX protein is closely related to HDM2 with which it shares different structural domains, parti...
The tumor suppressor p14arf interacts, in response to oncogenic signals, with the p53 E3-ubiquitin l...
SummaryCancer cells neutralize p53 by deletion, mutation, proteasomal degradation, or sequestration ...
The development of protein–protein interaction (PPI) inhibitors with therapeutic value is of increas...
Proteins that limit the activity of the tumour suppressor protein p53 are increasingly being targete...
p53 plays a critical role in regulating diverse biological processes: DNA repair, cell cycle arrest,...
p53 plays a critical role in regulating diverse biological processes: DNA repair, cell cycle arrest,...
p53 tumor suppressor activity is negatively regulated through binding to the oncogenic proteins Hdm2...
Upregulation of structurally homologous oncoproteins, Hdm2 and Hdmx, has been linked to the onset of...
The RING finger proteins HdmX and Hdm2 share significant structural and functional similarity. Hdm2 ...
The p53 tumor suppressor protein has a critical role in the cellular response to stress, and when ac...
Hdm2 (human MDM2) counteracts p53 function by direct binding to p53 and by ubiquitin-dependent p53 p...
We previously described a series of 314-helical β-peptides that bind the hDM2 protein and inhibit it...
Recently, we described a â-peptide foldamer, â53-1 (Figure 1A), that assembles into a 14-helix in aq...
Understanding how p53 activity is regulated is crucial in elucidating mechanisms of cellular defense...
The HDMX protein is closely related to HDM2 with which it shares different structural domains, parti...
The tumor suppressor p14arf interacts, in response to oncogenic signals, with the p53 E3-ubiquitin l...
SummaryCancer cells neutralize p53 by deletion, mutation, proteasomal degradation, or sequestration ...
The development of protein–protein interaction (PPI) inhibitors with therapeutic value is of increas...
Proteins that limit the activity of the tumour suppressor protein p53 are increasingly being targete...